Inhaled Sevofluran vs Endovenous Propofol for Colonoscopy
NCT ID: NCT03818048
Last Updated: 2019-01-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
32 participants
INTERVENTIONAL
2016-01-01
2016-12-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A longitudinal, randomized clinical study of 32 patients of both sexes ASA I-III, aged 18-80 years undergoing diagnostic colonoscopy, which was randomly divided into 2 groups. In both, intravenous induction with propofol (2-2.5 mg / kg) was performed, Group A remained sedated with propofol infusion (1-2 mg / kg / min); Group B by inhalation with sevoflurane at a concentration of 2 vol% through a nasal cannula with an oxygen flow.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Propofol-fentanyl-ketamine (PFK) Combination Versus General Anesthesia Using Propofol and Fentanyl in Patients Undergoing Endoscopic Procedures.
NCT04473846
Propofol-Ketamine vs Remifentanyl-Ketamine for Sedation in Pediatric Patients Undergoing Colonoscopy
NCT02602743
Remifentanil Versus Propofol for TCI Sedation of Patients Undergoing Gastrointestinal Endoscopic Procedures
NCT01746641
A Dose-ranging Study to Evaluate the Safety and Efficacy of LUSEDRA (Fospropofol Disodium) as an Intravenous Sedative for Diagnostic or Therapeutic Colonoscopy in Adult Special Populations
NCT01127438
Comparison Between Sevoflurane and Propofol for Maintenance of Sedation During ERCP
NCT05996588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group Propofol
propofol infusion
Propofol
after inicial bolus of propofol, remained sedated with propofol infusion (1-2 mg/kg/min)
Group Sevoflurane
inhalation with sevoflurane
Sevoflurane
after inicial bolus of propofol, remained sedated by inhalation with sevoflurane at a concentration of 2 vol% through a nasal cannula with an oxygen flow.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Propofol
after inicial bolus of propofol, remained sedated with propofol infusion (1-2 mg/kg/min)
Sevoflurane
after inicial bolus of propofol, remained sedated by inhalation with sevoflurane at a concentration of 2 vol% through a nasal cannula with an oxygen flow.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* physical status I, II and III according to the criteria of the American Society of Anesthesiology (ASA)
* patients who are going to undergo diagnostic colonoscopies
* patients who signed the informed consent
Exclusion Criteria
* patients with proven liver disease
* suspicion or confirmation of pregnancy
* antecedent or risk of malignant hyperthermia
* fasting less than 8 hours
* patients with psychic disorders or mental incapacity that make it difficult to understand their participation in the study
* patients who have acute illnesses that compromise their health for which the study cannot be performed
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centro Medico Docente la Trinidad
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Leopoldo Wulff
Principal Investigator, anesthesiologist.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CMDLT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.